256 related articles for article (PubMed ID: 21092000)
1. Sustained low hepatitis B viral load predicts good outcome after curative resection in patients with hepatocellular carcinoma.
An HJ; Jang JW; Bae SH; Choi JY; Cho SH; Yoon SK; Han JY; Lee KH; Kim DG; Jung ES
J Gastroenterol Hepatol; 2010 Dec; 25(12):1876-82. PubMed ID: 21092000
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus DNA and hepatocellular carcinoma recurrence after resection: the lower, the better!
You H; Jia JD
J Gastroenterol Hepatol; 2010 Dec; 25(12):1812-4. PubMed ID: 21091989
[No Abstract] [Full Text] [Related]
3. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS
J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297
[TBL] [Abstract][Full Text] [Related]
4. High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: a prospective cohort study.
Yang T; Lu JH; Zhai J; Lin C; Yang GS; Zhao RH; Shen F; Wu MC
Eur J Surg Oncol; 2012 Aug; 38(8):683-91. PubMed ID: 22621971
[TBL] [Abstract][Full Text] [Related]
5. Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.
Jin YJ; Shim JH; Lee HC; Yoo DJ; Kim KM; Lim YS; Suh DJ
J Gastroenterol Hepatol; 2011 Sep; 26(9):1380-8. PubMed ID: 21884247
[TBL] [Abstract][Full Text] [Related]
6. Perioperative reactivation of hepatitis B virus replication in patients undergoing partial hepatectomy for hepatocellular carcinoma.
Huang L; Li J; Lau WY; Yan J; Zhou F; Liu C; Zhang X; Shen J; Wu M; Yan Y
J Gastroenterol Hepatol; 2012 Jan; 27(1):158-64. PubMed ID: 21871026
[TBL] [Abstract][Full Text] [Related]
7. The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma.
Choi GH; Kim DH; Choi SB; Kang CM; Kim KS; Choi JS; Lee WJ; Han KH; Chon CY; Kim BR
J Gastroenterol Hepatol; 2009 Mar; 24(3):391-8. PubMed ID: 19032452
[TBL] [Abstract][Full Text] [Related]
8. Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.
Kubo S; Takemura S; Tanaka S; Shinkawa H; Nishioka T; Nozawa A; Kinoshita M; Hamano G; Ito T; Urata Y
World J Gastroenterol; 2015 Jul; 21(27):8249-55. PubMed ID: 26217076
[TBL] [Abstract][Full Text] [Related]
9. Higher efficacy of antiviral therapy after major hepatectomy in patients with hepatitis B virus-related hepatocellular carcinoma of less than 3 cm.
Zhang ZY; Zhou ZQ; Zhou GW
Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1116-24. PubMed ID: 25003747
[TBL] [Abstract][Full Text] [Related]
10. HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapy.
Hosaka T; Suzuki F; Kobayashi M; Hirakawa M; Kawamura Y; Yatsuji H; Sezaki H; Akuta N; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Kumada H
Liver Int; 2010 Nov; 30(10):1461-70. PubMed ID: 20840396
[TBL] [Abstract][Full Text] [Related]
11. Prognosis in liver transplantation recipients after hepatitis B virus recurrence.
Sun LY; Zhu ZJ; Qu W; Sun XY; Rao W; Liu Y
Hepatogastroenterology; 2014 Oct; 61(135):2047-51. PubMed ID: 25713909
[TBL] [Abstract][Full Text] [Related]
12. Early viral suppression predicts good postoperative survivals in patients with hepatocellular carcinoma with a high baseline HBV-DNA load.
Huang G; Yang Y; Shen F; Pan ZY; Fu SY; Lau WY; Zhou WP; Wu MC
Ann Surg Oncol; 2013 May; 20(5):1482-90. PubMed ID: 23247982
[TBL] [Abstract][Full Text] [Related]
13. Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels.
Huang G; Lai EC; Lau WY; Zhou WP; Shen F; Pan ZY; Fu SY; Wu MC
Ann Surg; 2013 Mar; 257(3):490-505. PubMed ID: 22868358
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma.
Kuzuya T; Katano Y; Kumada T; Toyoda H; Nakano I; Hirooka Y; Itoh A; Ishigami M; Hayashi K; Honda T; Goto H
J Gastroenterol Hepatol; 2007 Nov; 22(11):1929-35. PubMed ID: 17914972
[TBL] [Abstract][Full Text] [Related]
15. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.
Chen JD; Yang HI; Iloeje UH; You SL; Lu SN; Wang LY; Su J; Sun CA; Liaw YF; Chen CJ;
Gastroenterology; 2010 May; 138(5):1747-54. PubMed ID: 20114048
[TBL] [Abstract][Full Text] [Related]
16. HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma.
Sohn W; Paik YH; Kim JM; Kwon CH; Joh JW; Cho JY; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Ann Surg Oncol; 2014 Jul; 21(7):2429-35. PubMed ID: 24619495
[TBL] [Abstract][Full Text] [Related]
17. High hepatitis B virus DNA level in serum before liver transplantation increases the risk of hepatocellular carcinoma recurrence.
Li MR; Chen GH; Cai CJ; Wang GY; Zhao H
Digestion; 2011; 84(2):134-41. PubMed ID: 21502763
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of antiviral therapy after resection of hepatocellular carcinoma in the immune-active phase of hepatitis B virus infection.
Li N; Lai EC; Shi J; Guo WX; Xue J; Huang B; Lau WY; Wu MC; Cheng SQ
Ann Surg Oncol; 2010 Jan; 17(1):179-85. PubMed ID: 19727956
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B genotype C correlated with poor surgical outcomes for hepatocellular carcinoma.
Liang TJ; Mok KT; Liu SI; Huang SF; Chou NH; Tsai CC; Chen IS; Yeh MH; Chen YC; Wang BW
J Am Coll Surg; 2010 Nov; 211(5):580-6. PubMed ID: 20851644
[TBL] [Abstract][Full Text] [Related]
20. Interferon-α therapy after curative resection prevents early recurrence and improves survival in patients with hepatitis B virus-related hepatocellular carcinoma.
Qu LS; Jin F; Huang XW; Shen XZ
J Surg Oncol; 2010 Dec; 102(7):796-801. PubMed ID: 20886584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]